These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
86 related articles for article (PubMed ID: 8170669)
1. [Clinico-pharmacologic studies on pefloxacin]. Ludwig E; Székely E; Csiba A Orv Hetil; 1994 Mar; 135(13):687-92. PubMed ID: 8170669 [TBL] [Abstract][Full Text] [Related]
2. [Study of pefloxacin concentration in blood and sputum in the aged pneumonia patients with impairment of renal function]. Ma L; Sun C; Wu J Zhonghua Jie He He Hu Xi Za Zhi; 2001 Oct; 24(10):596-8. PubMed ID: 11770420 [TBL] [Abstract][Full Text] [Related]
3. Evaluation of the efficacy of sequential intravenous-oral administration of pefloxacin in community-acquired lower respiratory tract infections in patients with underlying conditions. Yap JC; Wang YT; Chan CC; Ng A; Poh SC Singapore Med J; 1995 Oct; 36(5):484-6. PubMed ID: 8882529 [TBL] [Abstract][Full Text] [Related]
4. NTP Toxicology and Carcinogenesis Studies of Pentachloroanisole (CAS No. 1825-21-4) in F344 Rats and B6C3F1 Mice (Feed Studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 1993 Apr; 414():1-284. PubMed ID: 12616284 [TBL] [Abstract][Full Text] [Related]
5. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653 [TBL] [Abstract][Full Text] [Related]
6. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis. Brandi L Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159 [TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics and tissue distribution of intravenous pefloxacin for antibiotic prophylaxis in biliary surgery. Gascón AR; Campo E; Olea E; Hernández RM; Calvo B; Errasti J; Pedraz JL Biopharm Drug Dispos; 2002 Oct; 23(7):293-300. PubMed ID: 12355580 [TBL] [Abstract][Full Text] [Related]
8. [The dobutamine-dopamine combination versus amrinone in congestive heart failure with a marked edematogenic sign complicated by functional kidney failure. A comparison between 2 different models of inotropic stimulation and diuresis potentiation]. De Vecchis R; Pucciarelli G; Nocerino L; Cocozza M; Setaro A; Torre G; Imperatore F Minerva Cardioangiol; 1998 May; 46(5):163-74. PubMed ID: 9842199 [TBL] [Abstract][Full Text] [Related]
9. Use of pefloxacin in urogenital infections. Csata S; Bocskai T Ther Hung; 1992; 40(2):72-5. PubMed ID: 1462279 [TBL] [Abstract][Full Text] [Related]
10. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289 [TBL] [Abstract][Full Text] [Related]
11. A randomized trial of pefloxacin plus klindamicin and cefoxitin in hepatobiliary and pancreatic surgery. Fried M; Peskova M Hepatogastroenterology; 1996; 43(7):306-8. PubMed ID: 8682484 [TBL] [Abstract][Full Text] [Related]
12. NTP technical report on the toxicity studies of Dibutyl Phthalate (CAS No. 84-74-2) Administered in Feed to F344/N Rats and B6C3F1 Mice. Marsman D Toxic Rep Ser; 1995 Apr; 30():1-G5. PubMed ID: 12209194 [TBL] [Abstract][Full Text] [Related]
13. [Clinical and pharmacokinetic study of pefloxacin in spontaneous ascitic fluid infections]. Ducroix JP; Hary L; Andrejak M; Smail A; Tondriaux A; Eb F; Baillet J Therapie; 1990; 45(6):461-5. PubMed ID: 2080483 [TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of brodimoprim in special populations. Stockis A; Borzio F; Deroubaix X; Gaspari F; Jeanbaptiste B; Lebacq E; Lins R; Pavesio D; Pelozi GC; Rosillon D J Chemother; 1993 Dec; 5(6):480-7. PubMed ID: 8195841 [TBL] [Abstract][Full Text] [Related]
16. Multiple-dose pharmacokinetics of pefloxacin in patients with hepatocellular deficiency. Galtier M; Bressolle F; de la Coussaye JE; Gomeni R; Joubert P; Gény F; Dubois A; Raffanel C; Saissi G; Eledjam JJ Clin Pharmacokinet; 1993 Nov; 25(5):415-23. PubMed ID: 8287635 [TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetic and pharmacodynamic properties of tramadol IR and SR in elderly patients: a prospective, age-group-controlled study. Likar R; Wittels M; Molnar M; Kager I; Ziervogel G; Sittl R Clin Ther; 2006 Dec; 28(12):2022-39. PubMed ID: 17296459 [TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of dalbavancin in patients with renal or hepatic impairment. Marbury T; Dowell JA; Seltzer E; Buckwalter M J Clin Pharmacol; 2009 Apr; 49(4):465-76. PubMed ID: 19318696 [TBL] [Abstract][Full Text] [Related]
19. NTP Toxicology and Carcinogenesis Studies of 1,4-Dichlorobenzene (CAS No. 106-46-7) in F344/N Rats and B6C3F1 Mice (Gavage Studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 1987 Jan; 319():1-198. PubMed ID: 12748734 [TBL] [Abstract][Full Text] [Related]
20. A study to evaluate the pharmacokinetics of oral 5-fluorouracil and eniluracil after concurrent administration to patients with refractory solid tumours and varying degrees of renal impairment (FUMA1005). O'Donnell A; Punt CJ; Judson I; Van Maanen L; Suttle AB; Ertel P; Beale P Cancer Chemother Pharmacol; 2003 Jan; 51(1):58-66. PubMed ID: 12497207 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]